Secondly, in addition to the decreased expression of NKp30, NKp46 and CD161, patients with active classical KS exhibited a specific down-modulation of NKG2D and a parallel defect in NK cell lytic capacity. This evidence concerns the gene NCR1 and Kaposi's sarcoma.